ACSL4 and hepatocellular carcinoma: Multivariate Cox analyses revealed that ACSL4 expression in HCC (hazard ratio [HR] = 4.229, 95% confidence interval [95%CI] = 1.189 ~ 15.042), TNM staging (HR = 5.704, 95%CI = 1.719 ~ 18.923), and early recurrence within 2 years (HR = 2.394, 95%CI = 1.032 ~ 5.555) are independent predictors of overall survival in HCC patients (Table 1).